Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steven Oberste

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
Science (New York, N.Y.)|March 16, 2002
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirusOlen Kew, Victoria Morris-Glasgow, Mauricio Landaverde, et al.
Journal of Clinical Microbiology|April 8, 2011
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogensMaja Kodani, Genyan Yang, Laura M Conklin, et al.
Lancet (London, England)|June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 studyPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Plos One|December 15, 2021
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panelJustin S Lee, Jason M Goldstein, Jonathan L Moon, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2022
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021Javier Martin, Cara C Burns, Jaume Jorba, et al.
Journal of Virology|February 15, 2013
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaCara C Burns, Jing Shaw, Jaume Jorba, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2022
Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater-New York, June-August 2022Ruth Link-Gelles, Emily Lutterloh, Patricia Schnabel Ruppert, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater - New York, June-August 2022Ruth Link-Gelles, Emily Lutterloh, Patricia Schnabel Ruppert, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022A Blythe Ryerson, Daniel Lang, Mohammed A Alazawi, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
Science (New York, N.Y.)|March 16, 2002
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirusOlen Kew, Victoria Morris-Glasgow, Mauricio Landaverde, et al.
Journal of Clinical Microbiology|April 8, 2011
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogensMaja Kodani, Genyan Yang, Laura M Conklin, et al.
Lancet (London, England)|June 9, 2019
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 studyPierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay, et al.
Plos One|December 15, 2021
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panelJustin S Lee, Jason M Goldstein, Jonathan L Moon, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2022
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021Javier Martin, Cara C Burns, Jaume Jorba, et al.
Journal of Virology|February 15, 2013
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaCara C Burns, Jing Shaw, Jaume Jorba, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2022
Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater-New York, June-August 2022Ruth Link-Gelles, Emily Lutterloh, Patricia Schnabel Ruppert, et al.
MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater - New York, June-August 2022Ruth Link-Gelles, Emily Lutterloh, Patricia Schnabel Ruppert, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022A Blythe Ryerson, Daniel Lang, Mohammed A Alazawi, et al.
Pageof 23